Most of them measured either cancer-related proteins (i.e., PSMA, PCA3, TMPRSS2:EGR, or PSA) or exosomal cell surface proteins (CD9, CD3, EpCAM, or CD81). This evidence concerns the gene FOLH1 and cancer.